Amexdrug Corporation
AXRXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$33882
P/E Ratio—
52W High$0.0002
52W Low$0.0001
Amexdrug Corporation (AXRX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AXRX · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.90M | $3.40M | $3.92M | $4.82M | $6.37M |
| Cost of Revenue | $1.75M | $2.32M | $2.88M | $3.83M | $4.81M |
| Gross Profit | $1.15M | $1.08M | $1.03M | $1.00M | $1.55M |
| Gross Margin %(computed) | 39.60% | 31.64% | 26.43% | 20.64% | 24.42% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.02M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $1.01M | $0.96M | $0.92M | $0.86M | $1.24M |
| Operating Income | $0.14M | $0.12M | $0.12M | $0.14M | $0.31M |
| Operating Margin %(computed) | 4.71% | 3.53% | 2.99% | 2.83% | 4.94% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.10M | $0.11M | $0.08M | $0.06M | $0.12M |
| Income Before Tax | $0.04M | $0.01M | $0.04M | $0.07M | $0.20M |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | $0.04M | $0.01M | $0.04M | $0.07M | $0.20M |
| Net Margin %(computed) | 1.39% | 0.34% | 0.92% | 1.54% | 3.08% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $0.04 | $0.00 |
| Wtd Avg Shares | 169.41M | 169.41M | 169.41M | 169.41M | 169.41M |
| EBITDA | $0.14M | $0.12M | $0.12M | $0.37M | $0.52M |
| EBITDA Margin %(computed) | 4.71% | 3.53% | 2.99% | 7.65% | 8.18% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Amexdrug Corporation data
About Amexdrug Corporation (AXRX) Income Statement
Amexdrug Corporation (AXRX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, AXRX reported revenue of $0.00B, gross profit of $0.00B (gross margin 39.60%), and net income of $0.00B — a net profit margin of 1.39%.
Frequently asked questions
AXRX · 4 questionsAmexdrug Corporation (AXRX) reported revenue of $0.00B for 2025, down 14.6% year-over-year.
AXRX revenueAXRX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09